A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in elderly asthmatics

Y Ishiura, M Fujimura, Y Shiba, N Ohkura… - Drug …, 2018 - thieme-connect.com
Background Asthma in the elderly population has been focused because it affects quality of
life and results in a higher hospitalization rate and mortality. Fluticasone furoate …

A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler

M Latorre, P Paggiaro, W Canonica… - Pulmonary …, 2015 - Elsevier
A good level of asthma control improves the quality of life of asthmatic patients and may
prevent future risk in term of exacerbations and decline of pulmonary function. However, in a …

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized …

K Furuhashi, T Fujisawa, D Hashimoto… - Journal of Asthma …, 2019 - Taylor & Francis
Introduction Fluticasone furoate (FF)/vilanterol (VI) dry powder inhaler (DPI) is the only once-
daily maintenance inhaled corticosteroid (ICS)/long-acting β2 adrenergic agonist (LABA) …

Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma

JL Pinnas, MJ Noonan, SF Weinstein… - Journal of …, 2005 - Taylor & Francis
In this randomized, double-blind, placebo-controlled trial, 397 patients with moderate to
severe asthma, previously treated with bronchodilators alone, received fluticasone …

Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild‐to‐moderate persistent asthma

DS Pearlman, D Peden, JJ Condemi… - Journal of …, 2004 - Taylor & Francis
The objective of this study was to compare the efficacy and safety of fluticasone propionate
(FP)(44 µg)/salmeterol (21 µg) delivered as two inhalations twice daily via a single …

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in patients with mild-to-moderate asthma

C Falcoz, J Horton, AE Mackie, SM Harding… - Clinical …, 2000 - Springer
Objective The aim of these studies was to compare the pharmacokinetics of inhaled
fluticasone propionate (FP) after repeated administration via the Diskus® or Diskhaler® dry …

Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment …

EM Kerwin, H Taveras, H Iverson, D Wayne… - Clinical drug …, 2016 - Springer
Abstract Background and Objective Metered-dose inhalers require patients to coordinate
inhalation with actuation. The present albuterol multi-dose dry-powder inhaler (mDPI) does …

Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose …

ED Bateman, V Silins, M Bogolubov - Respiratory medicine, 2001 - Elsevier
This multi-centre, randomized, double-blind, double-dummy, parallel-group study was
designed to investigate the hypothesis of equivalent efficacy and comparable safety of two …

[HTML][HTML] Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma

A Mukhopadhyay, M Waked, J Gogtay, V Gaur - Respiratory Medicine, 2020 - Elsevier
Introduction Pressurised metered dose inhalers (pMDIs) are effective drug delivery devices
prescribed in obstructive airway diseases due to their convenience, portability, ease of …

Comparison of patient-reported outcomes during treatment with adjustable-and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose …

RD O'Connor, DL Patrick, B Parasuraman… - Journal of …, 2010 - Taylor & Francis
Objective. Assessment of patient-reported outcomes is important in evaluating the impact of
asthma treatment. This study was conducted to compare effects of adjustable-and fixed-dose …